You can find some information about all this here. And, depending on what information you need, contact us at the numbers and websites below. We’re here to help.
For general inquiries: 1.800.727.6500
For our Diabetes Patient Assistance Program, affordability
and NovoCare services: 1.844.NOVO4ME (844.668.6463) or
For Rare Bleeding Disorder services, please visit NovoSecure.com
If you’re a healthcare professional: NovoMedLink is your source for diabetes product samples and support. For growth hormone, please contact your local representative.
During the global coronavirus outbreak, a key priority for Novo Nordisk is to safeguard the continued supply of our lifesaving medicines to patients. At present, we do not foresee a disruption in our ability to supply the U.S. market with our medicines, including insulin, growth hormone or medicines for rare bleeding disorders. We have an inventory policy that helps ensure long-term supply. This is important since our medicines are needed every day by patients all over the world.
We remain committed to doing our part for the communities we serve. We’ve provided more than a million dollars in monetary and in-kind donations to national relief organizations, as well as to New York City/New Jersey/Philadelphia relief efforts, including Direct Relief, AmeriCares, the NYC Emergency COVID-19 Relief Fund, the New Jersey Pandemic Relief Fund and the Philadelphia COVID-19 Relief Fund. Our relief efforts also included: